9-Feb-2026
No headlines found.
Business Wire (Tue, 27-Jan 8:15 AM ET)
Business Wire (Tue, 20-Jan 8:15 AM ET)
Business Wire (Thu, 15-Jan 8:15 AM ET)
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
Business Wire (Mon, 12-Jan 8:15 AM ET)
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
Business Wire (Fri, 9-Jan 7:00 AM ET)
Business Wire (Tue, 6-Jan 8:15 AM ET)
Hyperfine Announces Regulatory Approval of the Swoop System in India
Business Wire (Wed, 17-Dec 8:15 AM ET)
Business Wire (Mon, 15-Dec 8:15 AM ET)
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
Business Wire (Thu, 20-Nov 4:05 PM ET)
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
Business Wire (Wed, 19-Nov 8:15 AM ET)
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Hyperfine - Class A trades on the NASDAQ stock market under the symbol HYPR.
As of February 9, 2026, HYPR stock price climbed to $1.14 with 272,900 million shares trading.
HYPR has a beta of 0.89, meaning it tends to be less sensitive to market movements. HYPR has a correlation of 0.02 to the broad based SPY ETF.
HYPR has a market cap of $110.77 million. This is considered a Micro Cap stock.
Last quarter Hyperfine - Class A reported $3 million in Revenue and -$.14 earnings per share. This fell short of revenue expectation by $-83,000 and missed earnings estimates by -$.04.
In the last 3 years, HYPR traded as high as $3.28 and as low as $.53.
The top ETF exchange traded funds that HYPR belongs to (by Net Assets): VTI, VXF.
HYPR has underperformed the market in the last year with a price return of -33.3% while the SPY ETF gained +15.7%. However, in the short term, HYPR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.6% vs +3.8% return in SPY. But in the last 2 weeks, HYPR shares have been beat by the market, returning -8.1% compared to an SPY return of +0.7%.
HYPR support price is $1.04 and resistance is $1.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HYPR shares will trade within this expected range on the day.